Comparing the effects of bevacizumab and aflibercept in the treatment and outcome of patients with retinopathy of prematurity (ROP)
Not Applicable
Recruiting
- Conditions
- H35.1Retinopathy of prematurity.Retinopathy of prematurity
- Registration Number
- IRCT20240611062093N1
- Lead Sponsor
- Zahedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Completion of patient files
Patients who need treatment
Patients needing treatment with anti-VEGF drugs
Exclusion Criteria
Patients with underlying disease, including congenital glaucoma, congenital cataract
Patients with vitreous hemorrhages
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method